Physicians' knowledge, perceptions and behaviour towards antibiotic prescribing: A systematic review of the literature

Expert Review of Anti-Infective Therapy

Volumn 13, Issue 5, 2015, Pages 665-680

  Md Rezal, Rabiatul Salmi ^a   Hassali, Mohamed Azmi ^a   Alrasheedy, Alian A ^b   Saleem, Fahad ^a   Md Yusof, Faridah Aryani ^c   Godman, Brian ^d,e  

^a SCHOOL OF PHYSICS   (Malaysia)

^b QASSIM UNIVERSITY   (Saudi Arabia)

^c MINISTRY OF HEALTH   (Malaysia)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Antibiotics; Irrational use of medicines; Patients; Physicians; Prescribing behaviour; Resistance; Systematic reviews

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; AWARENESS; CLINICAL DECISION MAKING; COMMON COLD; DISEASE DURATION; DISEASE SEVERITY; DRUG INFORMATION; EXPECTATION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; PROFESSIONAL KNOWLEDGE; QUESTIONNAIRE; REVIEW; SYSTEMATIC REVIEW (TOPIC); TREATMENT OUTCOME; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; CLINICAL COMPETENCE; CLINICAL PRACTICE; HEALTH PERSONNEL ATTITUDE; STANDARDS;

ANTI-BACTERIAL AGENTS; ATTITUDE OF HEALTH PERSONNEL; CLINICAL COMPETENCE; DRUG PRESCRIPTIONS; HUMANS; PRACTICE PATTERNS, PHYSICIANS';

EID: 84927650204     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.2015.1025057     Document Type: Review

References (108)

1. HM Government. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. 2014. Available from: www.jpiamr. eu/wp-content/uploads/2014/12/AMR-Review-Paper-Tackling-a-crisis-for-the-health-and-wealth-of-nations-1-2.pdf [Last accessed December 2014]
2. Bosch F, Rosich L. The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel prize. Pharmacology 2008;82(3):171-9
3. Alharbi SA, Wainwright M, Alahmadi TA, et al. What if Fleming had not discovered penicillin? Saudi J Biol Sci 2014;21(4):289-93
4. Alanis AJ. Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res 2005;36(6):697-705
5. Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 2010;74(3):417-33
6. Almeman AA, Ibrahim MI, Rasool S. Cost analysis of medications used in upper respiratory tract infections and prescribing patterns in university sans Malaysia, Penang, Malaysia. Tropical J Pharmaceutical Res 2014;13(4):621-6
7. Kho B, Ong C, Tan F, et al. Antibiotic prescribing for upper respiratory tract infections in Sarawak district hospitals. Med J Malaysia 2013;68(2):136-40
8. Larsson M, Kronvall G, Chuc N, et al. Antibiotic medication and bacterial resistance to antibiotics: a survey of children in a Vietnamese community. Trop Med Int Health 2000;5(10):711-21
9. Nash DR, Harman J, Wald ER, et al. Antibiotic prescribing by primary care physicians for children with upper respiratory tract infections. Arch Pediatr Adolesc Med 2002;156(11):1114-19
10. Barnett ML, Linder JA. Antibiotic prescribing for adults with acute bronchitis in the United States, 1996-2010. JAMA 2014;311(19):2020-2
11. Hay AD, Costelloe C. Antibiotics for childhood urinary tract infections: can we be smarter?. Br J Gen Pract 2013;63:175-6
12. Goossens H, Ferech M, Vander Stichele R, et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365(9459):579-87
13. Kesselheim AS, Outterson K. Fighting antibiotic resistance: marrying new financial incentives to meeting public health goals. Health Aff (Millwood) 2010;29(9):1689-96
14. Conly J. Controlling antibiotic resistance by quelling the epidemic of overuse and misuse of antibiotics. Can Fam Physician 1998;44: 1769-73
15. World Health Organisation. WHO global strategy for containment of antimicrobial resistance. 2001. Available from: www.who. int/csr/resources/publications/drugresist/en/EGlobal-Strat.pdf
16. Costelloe C, Metcalfe C, Lovering A, et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010;340:c2096
17. Van Nguyen K, Do NT, Chandna A, et al. Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam. BMC Public Health 2013;13(1):1158
18. Laxminarayan R, Heymann DL. Challenges of drug resistance in the developing world. BMJ 2012;344(3):e1567
19. Holloway KA, Ivanovska V, Wagner AK, et al. Prescribing for acute childhood infections in developing and transitional countries, 1990-2009. Paediatr Int Child Health 2015;35(1):5-13
20. Holloway KA. Combating inappropriate use of medicines. Expert Rev Clin Pharmacol 2011;4(3):335-48
21. Kotwani A, Wattal C, Katewa S, et al. Factors influencing primary care physicians to prescribe antibiotics in Delhi India. Fam Pract 2010;27(6):684-90
22. Holloway K, Mathai E, Gray A. Surveillance of antimicrobial resistance in resource-constrained settings-experience from five pilot projects. Trop Med Int Health 2011;16(3):368-74
23. Holloway K, Mathai E, Gray A. Surveillance of community antimicrobial use in resource-constrained settings-experience from five pilot projects. Trop Med Int Health 2011;16(2):152-61
24. Radyowijati A, Haak H. Improving antibiotic use in low-income countries: an overview of evidence on determinants. Soc Sci Med 2003;57(4):733-44
25. Holloway KA, Henry D. WHO essential medicines policies and use in developing and transitional countries: an analysis of reported policy implementation and medicines use surveys. PLoS Med 2014;11(9):e1001724
26. Holloway KA, Ivanovska V, Wagner AK, et al. Have we improved use of medicines in developing and transitional countries and do we know how to? Two decades of evidence. Trop Med Int Health 2013;18(6):656-64
27. Earnshaw S, Mendez A, Monnet DL, et al. Global collaboration to encourage prudent antibiotic use. Lancet Infect Dis 2013; 13(12):1003-4
28. Schwartz RK, Soumerai SB, Avorn J. Physician motivations for nonscientific drug prescribing. Soc Sci Med 1989;28(6):577-82
29. Fakih MG, Hilu RC, Savoy-Moore RT, et al. Do resident physicians use antibiotics appropriately in treating upper respiratory infections? A survey of 11 programs. Clin Infect Dis 2003;37(6):853-6
30. Hassali MA, Kamil T, Faridah AMY, et al. General practitioners' knowledge, attitude and prescribing of antibiotics for upper respiratory tract infections in Selangor, Malaysia: findings and implications. Expert Rev Anti Infect Ther 2015;13(4)):511-20
31. Riaz H, Godman B, Hussain S, et al. Prescribing of bisphosphonates and antibiotics in Pakistan: challenges and opportunities for the future. J Pharm Health Serv Res 2015; In Press
32. Trap B, Hansen EH. Treatment of upper respiratory tract infections-a comparative study of dispensing and non-dispensing doctors. J Clin Pharm Ther 2002;27(4): 289-98
33. Li Y, Xu J, Wang F, et al. Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids. Health Aff (Millwood) 2012;31(5):1075-82
34. Park S, Soumerai SB, Adams AS, et al. Antibiotic use following a Korean national policy to prohibit medication dispensing by physicians. Health Policy Plan 2005;20(5): 302-9
35. Mohan S, Dharamraj K, Dindial R, et al. Physician behaviour for antimicrobial prescribing for paediatric upper respiratory tract infections: a survey in general practice in Trinidad, West Indies. Ann Clin Microbiol Antimicrob 2004;3(1):11
36. Mazzaglia G, Arcorac V, Cutroneo P, et al. Infectious diseases and antibiotic prescription in general practice. A surveillance study in Sicily. Malattie infettive in medicina generale e prescrizione di antibiotici Studio osservazionale in Sicilia. 1998;89(7-8):356-60
37. Chukwuani CM, Onifade M, Sumonu K. Survey of drug use practices and antibiotic prescribing pattern at a general hospital in Nigeria. Pharm World Sci 2002;24(5): 188-95
38. Rosman S, Le Vaillant M, Schellevis F, et al. Prescribing patterns for upper respiratory tract infections in general practice in France and in the Netherlands. Eur J Public Health 2008;18(3):312-16
39. Thriemer K, Katuala Y, Batoko B, et al. Antibiotic prescribing in DR Congo: a knowledge, attitude and practice survey among medical doctors and students. PLoS One 2013;8(2):e55495
40. Piddock LJ. Antibiotic Action: helping deliver action plans and strategies. Lancet Infect Dis 2013;13(12):1009-11
41. Chahwakilian P, Huttner B, Schlemmer B, Harbarth S. Impact of the French campaign to reduce inappropriate ambulatory antibiotic use on the prescription and consultation rates for respiratory tract infections. J Antimicrob Chemother 2011;66(12):2872-9
42. Sabuncu E, David J, Bernède-Bauduin C, et al. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med 2009;6(6):e1000084
43. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6(7): e1000097
44. Godman B, Acurcio F, Guerra Júnior AA, et al. Initiatives among authorities to improve the quality and efficiency of prescribing and the implications. J Pharma Care Health Sys 2014;1(3):15
45. Wong ZY, Alrasheedy A, Salee F, et al. Malaysian generic pharmaceutical industries: perspective from healthcare stakeholders. J Pharmaceutical Health Ser Res 2014;5(4): 193-203
46. Hassali MA, Wong ZY, Alrasheedy AA, et al. Perspectives of physicians practicing in low and middle income countries towards generic medicines: a narrative review. Health Policy 2014;117(3):297-310
47. Al-Gedadi NA, Hassali MA. Pharmacists' views on generic medicines: a review of the literature. J Generic Med 2008;5(3):209-18
48. Sutradhar KB, Saha A, Huda NH, et al. Irrational use of antibiotics and antibiotic resistance in southern rural bangladesh: perspectives from both the physicians and patients. Ann Res Rev Biology 2014;4(9): 1421-30
49. Cho HJ, Hong SJ, Park S. Knowledge and beliefs of primary care physicians, pharmacists, and parents on antibiotic use for the pediatric common cold. Soc Sci Med 2004;58(3):623-9
50. Chamany S, Schulkin J, Rose CE, et al. Knowledge, attitudes, and reported practices among obstetrician-gynecologists in the USA regarding antibiotic prescribing for upper respiratory tract infections. Infect Dis Obstet Gynecol 2005;13(1): 17-24
51. Navarro-San Francisco C, Del Toro MD, Cobo J, et al. Knowledge and perceptions of junior and senior Spanish resident doctors about antibiotic use and resistance: results of a multicenter survey. Enferm Infecc Microbiol Clin 2013;31(4):199-204
52. Adorka M, Dikokole M, Mitonga KH, et al. Healthcare providers' attitudes and perceptions in infection diagnosis and antibiotic prescribing in public health institutions in Lesotho: a cross sectional survey. Afr Health Sci 2013;13(2):344-50
53. Wester CW, Durairaj L, Evans AT, et al. Antibiotic resistance-A survey of physician perceptions. Arch Intern Med 2002; 162(19):2210-16
54. Srinivasan A, Song X, Richards A, et al. A survey of knowledge, attitudes, and beliefs of house staff physicians from various specialties concerning antimicrobial use and resistance. Arch Intern Med 2004;164(13): 1451-6
55. Grossman Z, del Torso S, Hadjipanayis A, et al. Antibiotic prescribing for upper respiratory infections: European primary paediatricians' knowledge, attitudes and practice. Acta Paediatr 2012;101(9):935-40
56. Wood F, Phillips C, Brookes-Howell L, et al. Primary care clinicians' perceptions of antibiotic resistance: a multi-country qualitative interview study. J Antimicrob Chemother 2013;68(1):237-43
57. Zaki A, Kheder S. A survey of patterns, attitudes, and beliefs of house staff physicians concerning antibiotic use in Khartoum state hospitals. Elixir Int J 2012;44:7251-5
58. Chandy SJ, Mathai E, Thomas K, et al. Antibiotic use and resistance: perceptions and ethical challenges among doctors, pharmacists and the public in Vellore, South India. IndJ Med Ethic 2012;10(1):20-7
59. Vazquez-Lago JM, Lopez-Vazquez P, Lopez-Duran A, et al. Attitudes of primary care physicians to the prescribing of antibiotics and antimicrobial resistance: a qualitative study from Spain. Fam Pract 2012;29(3):352-60
60. Butler CC, Rollnick S, Pill R, et al. Understanding the culture of prescribing: qualitative study of general practitioners and patients' perceptions of antibiotics for sore throats. BMJ 1998;317(7159):637-42
61. Pulcini C, Naqvi A, Gardella F, et al. Bacterial resistance and antibiotic prescriptions: perceptions, attitudes and knowledge of a sample of French GPs. Med Mal Infect 2010;40(12):703-9
62. Garćia C, Llamocca LP, Garćia K, et al. Knowledge, attitudes and practice survey about antimicrobial resistance and prescribing among physicians in a hospital setting in Lima, Peru. BMC Clin Pharmacol 2011;11(1):18
63. Pulcini C, Williams F, Molinari N, et al. Junior doctors' knowledge and perceptions of antibiotic resistance and prescribing: a survey in France and Scotland. Clin Microbiol Infect 2011;17(1):80-7
64. Zolaly MA, Hanafi MI. Factors Affecting Antibiotics' Prescription in General Pediatric Clinics. J Taibah Univer Med Sci 2011;6(1):33-41
65. Holloway K, Green T. Drug and therapeutics committees: a practical guide. Available from: http://apps.who.int/medicinedocs/pdf/s4882e/s4882e.pdf
66. Huttner B, Goossens H, Verheij T, et al. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis 2010;10(1):17-31
67. Sketris IS, Langille Ingram EM, Lummis HL. Strategic opportunities for effective optimal prescribing and medication management. Can J Clin Pharmacol 2009; 16(1):e103-25
68. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet 2003; 362(9391):1225-30
69. Sermet C, Andrieu V, Godman B, et al. Ongoing pharmaceutical reforms in France: implications for key stakeholder groups. Appl Health Econ Health Policy 2010;8(1): 7-24
70. Bjorkhem-Bergman L, Andersen-Karlsson E, Laing R, et al. Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations. Eur J Clin Pharmacol 2013;69 Suppl 1:73-8
71. Gustafsson LL, Wettermark B, Godman B, et al. The 'wise list'-a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm. Basic Clin Pharmacol Toxicol 2011;108(4): 224-33
72. Francke AL, Smit MC, de Veer AJ, et al. Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak 2008;8:38
73. Taba P, Rosenthal M, Habicht J, et al. Barriers and facilitators to the implementation of clinical practice guidelines: a cross-sectional survey among physicians in Estonia. BMC Health Serv Res 2012;12:455
74. Grimshaw J, Campbell M, Eccles M, Steen N. Experimental and quasi-experimental designs for evaluating guideline implementation strategies. Fam Pract 2000; 17(Suppl 1):S11-16
75. Cantillon P, Jones R. Does continuing medical education in general practice make a difference? BMJ 1999;318(7193):1276-9
76. Neuman J, Korenstein D, Ross JS, et al. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study. BMJ 2011;343: d5621
77. Parrino TA. Controlled trials to improve antibiotic utilization: a systematic review of experience, 1984-2004. Pharmacotherapy 2005;25(2):289-98
78. Godman B, Shrank W, Andersen M, et al. Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications. Expert Rev Pharmacoecon Outcomes Res 2010;10(6):707-22
79. Martikainen JE, Saastamoinen LK, Korhonen MJ, et al. Impact of restricted reimbursement on the use of statins in Finland: a register-based study. Med Care 2010;48(9):761-6
80. Moon J, Godman B, Petzold M, et al. Different initiatives across Europe to enhance losartan utilisation post generics: impact and implications. Front Pharmacol 2014;5:219
81. Voncina L, Strizrep T, Godman B, et al. Influence of demand-side measures to enhance renin-angiotensin prescribing efficiency in Europe: implications for the future. Expert Rev Pharmacoecon Outcomes Res 2011;11(4):469-79
82. Formoso G, Paltrinieri B, Marata AM, et al. Feasibility and effectiveness of a low cost campaign on antibiotic prescribing in Italy: community level, controlled, non-randomised trial. BMJ 2013;347:f5391
83. Furst J, Cizman M, Mrak J, et al. The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications. Expert Rev Anti Infect Ther 2015;13(2):279-89
84. Molstad S, Cars O, Struwe J. Strama-a Swedish working model for containment of antibiotic resistance. Euro Surveil 2008;13:46
85. Molstad S, Erntell M, Hanberger H, et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Stramaprogramme. Lancet Infect Dis 2008;8(2):125-32
86. NICE. Respiratory tract infections-antibiotic prescribing. Prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care. Available from: www.nice.org.uk/guidance/cg69/resources/cg69-respiratory-tract-infections-full-guideline3 [Last accessed July 2008]
87. Russell May J. Advantages of Having Pharmacists on the Antimicrobial Stewardship Team. Available from: www. pharmacytimes.com/videos/Advantages-of-Having-Pharmacists-on-the-Antimicrobial-Stewardship-Team
88. Teixeira Rodrigues A, Roque F, Falcao A, et al. Understanding physician antibiotic prescribing behaviour: a systematic review of qualitative studies. Int J Antimicrob Agents 2013;41(3):203-12
89. Weiss MC, Fitzpatrick R, Scott DK, et al. Pressures on the general practitioner and decisions to prescribe. Fam Prac 1996;13(5): 432-8
90. Stivers T, Mangione-Smith R, Elliott MN, et al. Why do physicians think parents expect antibiotics? What parents report vs what physicians believe. J Fam Pract 2003; 52(2):140-8
91. Stivers T. Parent resistance to physicians' treatment recommendations: one resource for initiating a negotiation of the treatment decision. Health Commun 2005;18(1): 41-74
92. Vinson DC, Lutz LJ. The effect of parental expectations on treatment of children with a cough: a report from ASPN. J Fam Pract 1993;37(1):23-7
93. Sarojini S, Faridah A, Lim CM, et al. Use of prescription medicines in Malaysia 2005. Med J Malaysia 2008;63(3):203-6
94. Sondergaard J, Vach K, Kragstrup J, et al. Impact of pharmaceutical representative visits on GPs' drug preferences. Fam Prac 2009;26(3):204-9
95. McGettigan P, Golden J, Fryer J, et al. Prescribers prefer people: the sources of information used by doctors for prescribing suggest that the medium is more important than the message. Br J Clin Pharmacol 2001;51(2):184-9
96. Civaner M. Sale strategies of pharmaceutical companies in a "pharmerging" country: the problems will not improve if the gaps remain. Health Policy 2012;106(3):225-32
97. Davis C, Abraham J. Is there a cure for corporate crime in the drug industry? BMJ 2013;346:f755
98. Ozieranski P, McKee M, King L. Pharmaceutical lobbying under postcommunism: universal or country-specific methods of securing state drug reimbursement in Poland? Health Econ Policy Law 2012;7(2):175-95
99. Araham J. Pharmaceuticalization of Society in Context: theoretical, Empirical and Health Dimensions. Sociology 2010;44:603-22
100. Al-Areefi MA, Hassali MA, Mohamed Ibrahim MI. The role of pharmaceutical marketing and other factors in prescribing decisions: the Yemeni experience. Res Soc Admin Pharma 2013; 9(6):981-8
101. Oshikoya KA, Oreagba I, Adeyemi O. Sources of drug information and their influence on the prescribing behaviour of doctors in a teaching hospital in Ibadan, Nigeria. Pan Afr Med J 2011;9:13
102. Spurling GK, Mansfield PR, Montgomery BD, et al. Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. PLoS Med 2010;7(10): e1000352
103. Chatterjee S, Patel HK, Sansgiry SS. An analysis of the warning letters issued by the FDA to pharmaceutical manufacturers regarding misleading health outcomes claims. Pharm Pract (Granada) 2012;10(4):194-8
104. Godman B, Gustafsson LL. A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing. Appl Health Econ Health Policy 2013;11(1):79-82
105. Yu SY, Yang BM, Kim JH. New anti-rebate legislation in South Korea. Appl Health Econ Health Policy 2013;11(4):311-18
106. Godman B, Wettermark B, Hoffmann M, et al. Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance. Expert Rev Pharmacoecon Outcomes Res 2009;9(1): 65-83
107. Roehr B. Drug companies will have to report all payments to US doctors from March 2014. BMJ 2013;346:f826
108. Holbrook A, Lexchin J, Pullenayegum E, et al. What do Canadians think about physician-pharmaceutical industry interactions? Health policy 2013;112(3):255-63